QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

AMETICKER

Ametek Inc/

BULLISH stock

Congress has disclosed 9 buys and 8 sells of AME (Ametek Inc/) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

9
Buy
8
Sell
+1
Net
9
Active politicians

Round-trip watch Still on the books

Members who disclosed buying AME and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Dan Newhouse 2025-08-18 $181.21 $241.12 +33.1% in profit
Alan Armstrong 2026-03-27 $208.62 $241.12 +15.6% in profit

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Technology. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
33.9
≈ in line with Technology (median 33.7)
how it's calculated
P/E = price ÷ earnings per share
$241.12 ÷ $7.11 = 33.9
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
4.73
▼ cheaper than Technology (median 6.2)
how it's calculated
P/B = price ÷ book value per share
$241.12 ÷ $51.00 = 4.73
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
23.98
▲ pricier than Technology (median 21.5)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($55.3B + $6.0B net debt) ÷ $2.6B = $61.3B ÷ $2.6B = 23.98
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

Legislation Related Legislation

Recent bills in this stock's sector (Technology). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.

BillTitlePolicy areaLatest action
HR 7022 Mystic Alerts Act Science, Technology, Communications 2026-10-22
S 5663 PROOF Act Science, Technology, Communications 2026-09-30
SRES 923 A resolution expressing support for the designation of October 4 through October 10, 2026, as "National 4-H Week". Science, Technology, Communications 2026-09-29
HR 10610 Stop Spam Calls Act Science, Technology, Communications 2026-09-24
HR 10594 Reliable Artificial Intelligence Research Act of 2026 Science, Technology, Communications 2026-09-24

17 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Alan Armstrong Senate BUY ◆ insider divergence Self 2026-03-27 116 days +13.8% $1K–$15K 82.9 ↗ eFD
Gilbert Cisneros House SELL ◆ insider convergence · moderate Self · 150 Main Street Trust > Bank of America 2026-02-10 24 days -4.8% $1K–$15K
0.1% of NW
14.3 ↗ filing
Gilbert Cisneros House BUY ◆ insider divergence · moderate Self · 150 Main Street Trust > Bank of America 2026-01-09 33 days +11.7% $1K–$15K
0.1% of NW
28.4 ↗ filing
Dan Newhouse House BUY ◆ insider divergence Spouse · Edward Jones IRA 2025-08-18 15 days +1.2% $1K–$15K
<0.1% of NW
62.8 ↗ filing
Rob Bresnahan House SELL ◆ insider convergence Self · JP Morgan Brokerage Account 2025-04-08 0 days 0.0% $1K–$15K
0.2% of NW
64.4 ↗ filing
Valerie Hoyle House SELL ◆ insider convergence · moderate Spouse · Fidelity Rollover IRA 2025-01-24 230 days +2.5% $1K–$15K
0.8% of NW
30.2 ↗ filing
Valerie Hoyle House BUY ◆ insider divergence · moderate Spouse · Fidelity Rollover IRA 2024-10-29 317 days +15.2% $1K–$15K
0.8% of NW
65.6 ↗ filing
Jonathan Jackson House BUY ◆ insider divergence · moderate Joint · Morgan Stanley Trust Account 2023-01-23 92 days — $15K–$50K
1.1% of NW
90.9 ↗ filing
Susie Lee House SELL Joint · DSL Living Trust > Bank of New York Brokerage Account 340 2022-11-30 5 days — $1K–$15K
0.2% of NW
15.7 ↗ filing
Susie Lee House SELL Joint 2020-12-11 21 days — $1K–$15K
0.2% of NW
22.3 ↗ filing
Susie Lee House BUY Joint 2019-11-08 23 days — $1K–$15K
0.2% of NW
40.4 ↗ filing
Susie Lee House BUY Joint 2019-10-03 28 days — $1K–$15K
0.2% of NW
75.9 ↗ filing
Gilbert Cisneros House SELL Self 2019-05-29 9 days — $15K–$50K
0.3% of NW
90.9 ↗ filing
Michael Conaway House SELL Spouse 2016-09-12 3 days — $1K–$15K 75.9 ↗ filing
Lamar Smith House SELL Self 2016-02-02 37 days — $1K–$15K 22.3 ↗ filing
Lamar Smith House BUY Self 2015-05-05 30 days — $1K–$15K 40.4 ↗ filing
Lamar Smith House BUY Self 2014-10-24 11 days — $1K–$15K 75.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in AME — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

3
Congress trades with insider convergence
5
…with insider divergence
53
Insider open-market trades

Of the congressional trades in AME, 3 coincided with corporate insiders moving the same way within 60 days, and 5 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-08-11 Stanage Nick L Director BUY $1.0M ↗ EDGAR
2026-08-07 Hermance David F. C-suite SELL $1.7M ↗ EDGAR
2026-03-24 AMATO THOMAS A Director SELL $115K ↗ EDGAR
2025-12-22 MONTGOMERY THOMAS M Other SELL $1.3M ↗ EDGAR
2025-12-15 Marecic Thomas C Other SELL $2.9M ↗ EDGAR
2025-12-12 ZAPICO DAVID A C-suite SELL $5.7M ↗ EDGAR
2025-11-25 ZAPICO DAVID A C-suite SELL $1.4M ↗ EDGAR
2025-11-25 ZAPICO DAVID A C-suite SELL $5.1M ↗ EDGAR
2025-11-25 ZAPICO DAVID A C-suite SELL $10.8M ↗ EDGAR
2025-11-12 Speranza Emanuela C-suite SELL $540K ↗ EDGAR
2025-10-31 Oscher Ronald J C-suite SELL $5.3M ↗ EDGAR
2025-09-11 Hardin John Wesley Other SELL $1.5M ↗ EDGAR
2025-03-27 AMATO THOMAS A Director SELL $125K ↗ EDGAR
2025-03-03 Kohlhagen Steven W Director SELL $250K ↗ EDGAR
2024-11-26 ZAPICO DAVID A C-suite SELL $2.1M ↗ EDGAR
2024-11-26 ZAPICO DAVID A C-suite SELL $2.4M ↗ EDGAR
2024-11-26 Speranza Emanuela C-suite SELL $313K ↗ EDGAR
2024-11-26 Speranza Emanuela C-suite SELL $1.0M ↗ EDGAR
2024-11-25 ZAPICO DAVID A C-suite SELL $11.8M ↗ EDGAR
2024-11-25 ZAPICO DAVID A C-suite SELL $7.6M ↗ EDGAR
2024-11-22 CIAMPITTI TONY J Other SELL $3.2M ↗ EDGAR
2024-11-13 Hardin John Wesley Other SELL $3.8M ↗ EDGAR
2024-11-08 Hermance David F. C-suite SELL $1.2M ↗ EDGAR
2024-09-25 Kohlhagen Steven W Director SELL $165K ↗ EDGAR
2024-09-25 Kohlhagen Steven W Director SELL $86K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
◆ insider 2026-08-11 Stanage Nick L Director BUY $1.0M
◆ insider 2026-08-07 Hermance David F. C-suite SELL $1.7M
Congress 2026-03-27 Alan Armstrong BUY $1K–$15K
◆ insider 2026-03-24 AMATO THOMAS A Director SELL $115K
Congress 2026-02-10 Gilbert Cisneros SELL $1K–$15K
Congress 2026-01-09 Gilbert Cisneros BUY $1K–$15K
◆ insider 2025-12-22 MONTGOMERY THOMAS M Other SELL $1.3M
◆ insider 2025-12-15 Marecic Thomas C Other SELL $2.9M
◆ insider 2025-12-12 ZAPICO DAVID A C-suite SELL $5.7M
◆ insider 2025-11-25 ZAPICO DAVID A C-suite SELL $1.4M
◆ insider 2025-11-25 ZAPICO DAVID A C-suite SELL $5.1M
◆ insider 2025-11-25 ZAPICO DAVID A C-suite SELL $10.8M
◆ insider 2025-11-12 Speranza Emanuela C-suite SELL $540K
◆ insider 2025-10-31 Oscher Ronald J C-suite SELL $5.3M
◆ insider 2025-09-11 Hardin John Wesley Other SELL $1.5M
Congress 2025-08-18 Dan Newhouse BUY $1K–$15K
Congress 2025-04-08 Rob Bresnahan SELL $1K–$15K
◆ insider 2025-03-27 AMATO THOMAS A Director SELL $125K
◆ insider 2025-03-03 Kohlhagen Steven W Director SELL $250K
Congress 2025-01-24 Valerie Hoyle SELL $1K–$15K
◆ insider 2024-11-26 ZAPICO DAVID A C-suite SELL $2.1M
◆ insider 2024-11-26 ZAPICO DAVID A C-suite SELL $2.4M
◆ insider 2024-11-26 Speranza Emanuela C-suite SELL $313K
◆ insider 2024-11-26 Speranza Emanuela C-suite SELL $1.0M

FAQ Common questions

How much has Congress traded AME?

9 disclosed buys and 8 sells of AME (Ametek Inc/) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade AME?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.